BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/27/2018 1:56:41 PM | Browse: 142 | Download: 75
Publication Name World Journal of Hepatology
Manuscript ID 41170
Country of Manuscript Source Greece
Received
2018-07-31 02:34
Peer-Review Started
2018-07-31 09:14
To Make the First Decision
2018-08-21 01:48
Return for Revision
2018-08-22 01:10
Revised
2018-09-10 20:14
Second Decision
2018-09-12 10:29
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-10-10 05:46
Articles in Press
2018-10-10 05:46
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2018-11-21 08:39
Publish the Manuscript Online
2018-11-27 13:56
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Editorial
Article Title Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle?
Manuscript Source Invited Manuscript
All Author List Maria Kalogirou and Emmanouil Sinakos
ORCID
Author(s) ORCID Number
Maria Kalogirou http://orcid.org/orcid.org/0000-0001-9985-4038
Emmanouil Sinakos http://orcid.org/0000-0003-0923-050X
Funding Agency and Grant Number
Corresponding author Emmanouil Sinakos, MD, PhD, Assistant Professor, 4th Department of Internal Medicine, Hippocrates Hospital, Aristotle University of Thessaloniki, 49, Konstantinopoleos Street, Thessaloniki 54642, Greece. em_sinakos@yahoo.com
Keywords Nonalcoholic steatohepatitis; Cirrhosis; Glucagon-like peptide-1 receptor agonists; Nonalcoholic fatty liver disease
Core Tip There is an urgent need for an effective treatment of nonalcoholic fatty liver disease (NAFLD). Growing evidence indicates that reducing insulin resis­tance can result in improvement of the biochemical and histological features of patients with nonalcoholic steatohepatitis (NASH). However, no antidiabetic agent to date has been proven as both safe and effe­ctive for the treatment of patients with NASH. Re­cent studies have demonstrated that glucagon-like peptide-1 agonists, a novel class of antidiabetic drugs, may be effective in slowing the progression of NAFLD, highlighting their potential role in the treatment of this complex disease.
Publish Date 2018-11-27 13:56
Citation Kalogirou M, Sinakos E. Treating nonalcoholic steatohepatitis with antidiabetic drugs: Will GLP-1 agonists end the struggle? World J Hepatol 2018; 10(11): 790-794
Url http://www.wjgnet.com/1948-5182/full/v10/i11/790.htm
DOI http://dx.doi.org/10.4254/wjh.v10.i11.790
Full Article (PDF) WJH-10-790.pdf
Full Article (Word) WJH-10-790.doc
Manuscript File 41170-Review.docx
Answering Reviewers 41170-Answering reviewers.pdf
Audio Core Tip 41170-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 41170-Conflict-of-interest statement.pdf
Copyright License Agreement 41170-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 41170-Language certificate.pdf
Peer-review Report 41170-Peer-review(s).pdf
Scientific Misconduct Check 41170-Scientific misconduct check.pdf
Scientific Editor Work List 41170-Scientific editor work list.pdf